Bay Area Cancer Research Group, LLC

Concord, California 94523

0 studies enrolling now · 6 studies all time

What they study most

Breast Cancer, Chronic Idiopathic Thrombocytopenic Purpura, Metastatic Pancreatic Cancer, Non-small Cell Lung Cancer, Ovarian Neoplasms, Pancreatic Cancer, Purpura, Thrombocytopenic, Idiopathic

Studies at this site

• Study of AKR-501 Tablets Taken Orally Once Daily for 28 Days in Patients With Chronic Idiopathic Thrombocytopenic Purpura (ITP) — Completed
• Phase 3 Randomized Study of Telcyta + Doxorubicin Versus Doxorubicin in Platinum Refractory or Resistant Ovarian Cancer — Stopped early
• APRiCOT-P: Study of Apricoxib With Gemcitabine and Erlotinib to Treat Advanced Pancreatic Cancer — Completed
• Evaluation of Efficacy, Safety and Tolerability of Targretin Capsules in Patients With Advanced or Metastatic Non-small Cell Lung Cancer — Completed
• TLK286 (Telcyta) in Combination With Carboplatin (Paraplatin) Versus Doxil in Platinum Refractory or Resistant Ovarian Cancer — Completed
• APRiCOT-B: Study to Evaluate Apricoxib in Combination With Lapatinib and Capecitabine in the Treatment of HER2/Neu+ Breast Cancer (TP2001-202) — Stopped early